COMPANY
Centrose LLC
NIH awards 7
- NIH award 1R43CA183223-01 FY2014: $224,734 awarded for that fiscal year; activity R43 (SBIR); PI PRUDENT, JAMES R.; recipient as written: CENTROSE, LLC, MIDDLETON, WI. A Novel Antibody Drug Conjugate for Metastatic R source ↗
- NIH award 1R43CA159720-01 FY2011: $199,122 awarded for that fiscal year; activity R43 (SBIR); PI PRUDENT, JAMES R.; recipient as written: CENTROSE, LLC, MIDDLETON, WI. A new paradigm for antibody-directed conjugates source ↗
- NIH award 3R43AI082684-01S1 FY2009: $8,400 awarded for that fiscal year; activity R43 (SBIR); PI HUTCHINSON, CHARLES R; recipient as written: CENTROSE, LLC, MIDDLETON, WI. Amphotericin B Analogs source ↗
- NIH award 1R43AI082684-01 FY2009: $277,253 awarded for that fiscal year; activity R43 (SBIR); PI HUTCHINSON, CHARLES R; recipient as written: CENTROSE, LLC, MIDDLETON, WI. Amphotericin B Analogs source ↗
- NIH award 1R43GM083362-01 FY2008: $198,836 awarded for that fiscal year; activity R43 (SBIR); PI HUTCHINSON, CHARLES R; recipient as written: CENTROSE, LLC, MIDDLETON, WI. Automation of Neoglycoside Synthesis source ↗
- NIH award 1R43CA130193-01A1 FY2007: $163,192 awarded for that fiscal year; activity R43 (SBIR); PI HUTCHINSON, CHARLES R; recipient as written: CENTROSE, LLC, MADISON, WI. cardiac neoglycosides as cancer drugs source ↗
- NIH award 1R43AI075704-01 FY2007: $244,089 awarded for that fiscal year; activity R43 (SBIR); PI HUTCHINSON, CHARLES R; recipient as written: CENTROSE, LLC, MADISON, WI. novel macrolides as anti-infective drugs source ↗